Ekso Bionics Holdings, Inc. (EKSO) Given $13.50 Consensus Price Target by Analysts
Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) have received an average broker rating score of 1.00 (Strong Buy) from the four brokers that cover the stock, Zacks Investment Research reports. Four research analysts have rated the stock with a strong buy rating.
Brokerages have set a 12-month consensus price target of $13.50 for the company and are predicting that the company will post ($0.41) EPS for the current quarter, according to Zacks. Zacks has also assigned Ekso Bionics Holdings an industry rank of 158 out of 265 based on the ratings given to its competitors.
A number of research firms recently issued reports on EKSO. B. Riley began coverage on shares of Ekso Bionics Holdings in a research report on Wednesday, September 21st. They set a “buy” rating and a $8.00 price objective for the company. Zacks Investment Research cut shares of Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 13th. SunTrust Banks Inc. began coverage on shares of Ekso Bionics Holdings in a research report on Thursday, October 13th. They set a “buy” rating and a $8.00 price objective for the company. Finally, Rodman & Renshaw reiterated a “buy” rating on shares of Ekso Bionics Holdings in a research report on Sunday, July 31st.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/ekso-bionics-holdings-inc-ekso-given-13-50-consensus-price-target-by-analysts.html
Ekso Bionics Holdings (NASDAQ:EKSO) traded down 3.9725% during midday trading on Wednesday, reaching $5.5888. 157,128 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $4.54 and its 200 day moving average price is $5.42. Ekso Bionics Holdings has a 1-year low of $3.45 and a 1-year high of $10.08. The firm’s market cap is $91.84 million.
Ekso Bionics Holdings (NASDAQ:EKSO) last issued its earnings results on Thursday, July 28th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.28) by $0.33. Equities research analysts anticipate that Ekso Bionics Holdings will post ($1.74) EPS for the current year.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.